Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease.
Advanced liver disease
Comorbidities
Health care costs
Health utilities
Mental health
Physical functioning
QALYs/ DALYs
Work productivity
Journal
Clinics in liver disease
ISSN: 1557-8224
Titre abrégé: Clin Liver Dis
Pays: United States
ID NLM: 9710002
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
medline:
10
4
2023
entrez:
6
4
2023
pubmed:
7
4
2023
Statut:
ppublish
Résumé
In addition to adverse clinical outcomes such as liver-related morbidity and mortality, nonalcoholic fatty liver disease (NAFLD) is associated with a substantial public health and economic burden and could also potentially impair health-related quality of life and other patient-reported outcomes. The disease also affects multiple aspects of patients' quality of life which are the most pronounced in physical health-related and fatigue domains as well as work productivity, and get more severe in patients with advanced liver disease or with non-hepatic comorbidities. The economic burden of NAFLD is substantial and is increasing, with the highest costs in those with advanced disease.
Identifiants
pubmed: 37024220
pii: S1089-3261(23)00007-7
doi: 10.1016/j.cld.2023.01.007
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
483-513Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.